Damon Provides Operational Business Update and Reports FY25 Q2 Results
FY25 Q2 Accomplishments and Highlights:
- The Company became publicly traded on NASDAQ under the symbol DMN
- Co-founder
Dominique (Dom) Kwong appointed as interim CEO andShashi Tripathi appointed as Chairman of the Board to drive operational excellence and accelerate execution of the company's business plans - Launched Damon 2.0 strategy focused on expanding total addressable market while accelerating and diversifying potential revenue generation through multiple channels
- Progressed to asset/capital-light partnership model to support sustainable growth strategy
- Established four core potential revenue verticals: Data Intelligence, Personal Mobility, Licensing and Engineering Services, and Special Projects
- Improved Balance Sheet position compared to prior year through conversion of convertible debt
- Secured
$10 million equity line of credit financing facility
"In Q2, Damon executed pivotal strategic shifts, including key leadership transitions and the introduction of our Damon 2.0 strategy," said
"Moving forward, we're implementing an asset-light business model through strategic partnerships, bolstered by our new
Financial Results for FY25 Q2 (ended
Financial Performance:
- Net income in the quarter was approximately $32.5 million, or $2.51 per diluted share, compared to a net loss of $7.1 million, or $(2.76) per diluted share, in the same period last year
Cash, Financing, Liabilities:
- Total cash was
$789k as atDecember 31, 2024 compared to$396k year endedJune 30, 2024 - Total Liabilities reduced to
$17.2 million as atDecember 31, 2024 compared to$52.2 million year endedJune 30, 2024 - Stockholders' Deficit reduced to
$974k as atDecember 31, 2024 compared to$50.4 million year endedJune 30, 2024 - Financing activities after the quarter ended in the amount of
$7 million compared to$8.7 million in the same period last year
Operating Performance:
- Operating expenses were approximately $5.5 million in the quarter, compared to $2.2 million in the same period last year
- General and administrative expenses were approximately $2.1 million compared to $1.8 million in the same period last year
About Damon
Damon Inc. is a designer and developer of personal mobility products and technology solutions that integrate AI-driven safety systems, smart electrification, and user-driven design to revolutionize sustainable transportation. Operating across four potential revenue verticals - Data Intelligence & Services, Engineering Services, Personal Mobility Products, and Special Projects – Damon believes it is positioned to capture a significant share of the
1 Source McKinsey Report on Micromobility (2022) |
FORWARD LOOKING STATEMENTS
This press release contains forward-looking information or forward-looking statements under applicable Canadian and
Forward-looking statements in this press release include, but are not limited to, statements relating to our strategic initiatives, revenue expansion plans, business model evolution, and expected efficiency improvements and growth.
In developing the forward-looking statements in this press release, we have applied several material assumptions, including the general business and economic conditions of the industries and countries in which Damon operates, and general market conditions. Many risks, uncertainties, and other factors could cause the actual results of Damon to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to, our history of losses, our ability to implement our growth strategy and achieve profitability, our limited operating history with recent acquisitions, our ability to obtain adequate financing as needed, our ability to continue as a going concern, our status as a foreign private issuer, our ability to maintain compliance with Nasdaq's continued listing requirements, customer demand for or acceptance of our products and services, the impact of competitive or alternative products, technologies, and pricing, emerging competition and rapidly advancing technology that may outpace our own, our ability to manufacture or distribute products and secure strategic supply and manufacturing arrangements, our ability to protect our intellectual property, impact of any changes in existing or future regulatory and tax regimes applying to our business, our ability to successfully consummate strategic transactions and integrate companies or technologies we acquire, our ability to attract and retain management and employees with specialized knowledge and technical skills, our ability to develop and maintain effective internal controls, general economic conditions and events and the impact they may have on us and our customers, including but not limited to increases in inflation rates and rates of interest, supply chain challenges, increased costs for materials and labor, cybersecurity threats, and conflicts such as those in
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of the press release or as of the date otherwise specifically indicated herein. Due to risks and uncertainties, events may differ materially from current expectations. Damon disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required pursuant to applicable securities law. All forward-looking statements contained in the press release are expressly qualified in their entirety by this cautionary statement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/damon-provides-operational-business-update-and-reports-fy25-q2-results-302377737.html
SOURCE DAMON Motors Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin to acquire Alesta Therapeutics for $275M upfront
- Curaleaf launches hostile takeover bid for Aurora Cannabis at $4/share
- CARsgen Therapeutics Announces 2026 Interim Results
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share